114 related articles for article (PubMed ID: 15265773)
1. Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors.
Sengupta S; Wasylyk B
Ann N Y Acad Sci; 2004 Jun; 1024():54-71. PubMed ID: 15265773
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid and sex hormone receptors: clinical implications and therapeutic relevance.
Stefanaki C; Chrousos GP; Katsambas A
Dermatol Clin; 2007 Oct; 25(4):503-13, viii. PubMed ID: 17903609
[TBL] [Abstract][Full Text] [Related]
3. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of prostate cancer cell survival after inhibition of AR expression.
Cohen MB; Rokhlin OW
J Cell Biochem; 2009 Feb; 106(3):363-71. PubMed ID: 19115258
[TBL] [Abstract][Full Text] [Related]
5. Opposite effects of histone deacetylase inhibitors on glucocorticoid and estrogen signaling in human endometrial Ishikawa cells.
Rocha W; Sanchez R; Deschênes J; Auger A; Hébert E; White JH; Mader S
Mol Pharmacol; 2005 Dec; 68(6):1852-62. PubMed ID: 16186250
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor activity is inhibited in response to genotoxic agents in a p53-independent manner.
Mantoni TS; Reid G; Garrett MD
Oncogene; 2006 May; 25(22):3139-49. PubMed ID: 16434973
[TBL] [Abstract][Full Text] [Related]
7. The mechanisms of tumor suppressor effect of glucocorticoid receptor in skin.
Chebotaev D; Yemelyanov A; Budunova I
Mol Carcinog; 2007 Aug; 46(8):732-40. PubMed ID: 17538956
[TBL] [Abstract][Full Text] [Related]
8. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
9. 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.
Chang NS; Schultz L; Hsu LJ; Lewis J; Su M; Sze CI
Oncogene; 2005 Jan; 24(4):714-23. PubMed ID: 15580310
[TBL] [Abstract][Full Text] [Related]
10. Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer.
Reddy GP; Barrack ER; Dou QP; Menon M; Pelley R; Sarkar FH; Sheng S
J Cell Biochem; 2006 Aug; 98(6):1408-23. PubMed ID: 16619263
[TBL] [Abstract][Full Text] [Related]
11. p53 and its downstream proteins as molecular targets of cancer.
Sun Y
Mol Carcinog; 2006 Jun; 45(6):409-15. PubMed ID: 16652354
[TBL] [Abstract][Full Text] [Related]
12. Function of nuclear sex hormone receptors in gene regulation.
Kato S; Sato T; Watanabe T; Takemasa S; Masuhiro Y; Ohtake F; Matsumoto T
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():4-9. PubMed ID: 16273365
[TBL] [Abstract][Full Text] [Related]
13. Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma.
Smith RA; Lea RA; Weinstein SR; Griffiths LR
Cancer Lett; 2007 Sep; 255(1):77-84. PubMed ID: 17512111
[TBL] [Abstract][Full Text] [Related]
14. The androgen receptor DNA-binding domain determines androgen selectivity of transcriptional response.
Verrijdt G; Tanner T; Moehren U; Callewaert L; Haelens A; Claessens F
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1089-94. PubMed ID: 17073757
[TBL] [Abstract][Full Text] [Related]
15. Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer.
Yan TZ; Jin FS; Xie LP; Li LC
Urol Int; 2008; 81(2):228-33. PubMed ID: 18758226
[TBL] [Abstract][Full Text] [Related]
16. Actions of steroids in mitochondria.
Gavrilova-Jordan LP; Price TM
Semin Reprod Med; 2007 May; 25(3):154-64. PubMed ID: 17447205
[TBL] [Abstract][Full Text] [Related]
17. The role of p53 in apoptosis.
Amaral JD; Xavier JM; Steer CJ; Rodrigues CM
Discov Med; 2010 Feb; 9(45):145-52. PubMed ID: 20193641
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
Carruba G
J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
[TBL] [Abstract][Full Text] [Related]
19. Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients.
Swellam M; Ismail M; Eissa S; Hamdy M; Mokhtar N
IUBMB Life; 2004 Aug; 56(8):483-90. PubMed ID: 15545228
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival.
Sun C; Shi Y; Xu LL; Nageswararao C; Davis LD; Segawa T; Dobi A; McLeod DG; Srivastava S
Oncogene; 2006 Jun; 25(28):3905-13. PubMed ID: 16636679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
